The PepT1-transportable soy tripeptide VPY reduces intestinal inflammation

Biochimica et Biophysica Acta - General Subjects

Volumn 1820, Issue 11, 2012, Pages 1753-1763

  Kovacs Nolan, Jennifer ^a   Zhang, Hua ^a   Ibuki, Masahisa ^b   Nakamori, Toshihiro ^b   Yoshiura, Keiko ^c   Turner, Patricia V ^a   Matsui, Toshiro ^c   Mine, Yoshinori ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b FUJI OIL CO LTD   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Anti inflammatory; Dextran sodium sulfate (DSS); Inflammatory bowel disease (IBD); PepT1; Pro inflammatory cytokine; Soy peptide

Indexed keywords

ANTIINFLAMMATORY AGENT; DOCUSATE SODIUM; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOPEROXIDASE; PEPTIDE TRANSPORTER 1; SOYBEAN PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VALYLPROLYLTYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLITIS; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG TRANSPORT; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VIVO STUDY; INTESTINE EPITHELIUM CELL; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; WEIGHT REDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CACO-2 CELLS; COLITIS; CYTOKINES; HUMANS; INTERLEUKIN-6; MICE; OLIGOPEPTIDES; PEROXIDASE; SOYBEAN PROTEINS; SYMPORTERS; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 84864825178     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2012.07.007     Document Type: Article

References (53)

1. R.B. Sartor Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis Nat. Clin. Pract. Gastroenterol. Hepatol. 3 2006 390 407
2. M.I. Torres, and A. Rios Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy World J. Gastroenterol. 14 2008 1972 1980
3. S. de Silva, S. Devlin, and R. Panaccione Optimizing the safety of biologic therapy for IBD Nat. Rev. Gastroenterol. Hepatol. 7 2010 93 101
4. O.H. Nielsen, J.B. Seidelin, L.K. Munck, and G. Rogler Use of biological molecules in the treatment of inflammatory bowel disease J. Intern. Med. 270 2011 15 28
5. S.A. Adibi The oligopeptide transporter (Pept-1) in human intestine: biology and function Gastroenterology 113 1997 332 340
6. H. Daniel Molecular and integrative physiology of intestinal peptide transport Annu. Rev. Physiol. 66 2004 361 384
7. B. Brodin, C.U. Nielsen, B. Steffansen, and S. Frøkjaer Transport of peptidomimetic drugs by the intestinal di/tri-peptide transporter, PepT1 Pharmacol. Toxicol. 90 2002 285 296
8. G.L. Amidon, and H.J. Lee Absorption of peptide and peptidomimetic drugs Annu. Rev. Pharmacol. Toxicol. 34 1994 321 341
9. M.E. Ganapathy, M. Brandsch, P.D. Prasad, V. Ganapathy, and F.H. Leibach Differential recognition of beta -lactam antibiotics by intestinal and renal peptide transporters, PEPT1 and PEPT2 J. Biol. Chem. 270 1995 25672 25677
10. P.D. Bailey, C.A. Boyd, I.D. Collier, J.P. George, G.L. Kellett, D. Meredith, K.M. Morgan, R. Pettecrew, and R.A. Price Affinity prediction for substrates of the peptide transporter PepT1 Chem. Commun. 3 2006 323 325
11. D. Merlin, M. Si-Tahar, S.V. Sitaraman, K. Eastburn, I. Williams, X. Liu, M.A. Hediger, and J.L. Madara Colonic epithelial hPepT1 expression occurs in inflammatory bowel disease: transport of bacterial peptides influences expression of MHC class 1 molecules Gastroenterology 120 2001 1666 1679
12. S.A. Ingersoll, S. Ayyadurai, M.A. Charania, H. Laroui, Y. Yan, and D. Merlin The role and pathophysiological relevance of membrane transporter PepT1 in intestinal inflammation and inflammatory bowel disease Am. J. Physiol. Gastrointest. Liver Physiol. 302 2012 G484 G492
13. G. Dalmasso, L. Charrier-Hisamuddin, H.T. Nguyen, Y. Yan, S. Sitaraman, and D. Merlin PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation Gastroenterology 134 2008 166 178
14. J. Isanga, and G.-N. Zhang Soybean bioactive components and their implications to health-a review Food Rev. Int. 24 2008 252 276
15. B.F. Gibbs, A. Zougman, R. Masse, and C. Mulligan Production and characterization of bioactive peptides from soy hydrolysate and soy-fermented food Food Res. Int. 37 2004 123 131
16. K.G. Malikarjun-Gouda, L.R. Gowda, A.G. Appu Rao, and V. Prakesh Angiotensin I-converting enzyme inhibitory peptide derived from glycinin, the 11S globulin of soybean (Glycine max) J. Agric. Food Chem. 54 2006 4568 4573
17. T. Tsuruki, K. Kishi, M. Takahashi, M. Tanaka, T. Matsukawa, and M. Yoshikawa Soymetide, an immunostimulating peptide derived from soybean β-conglycinin, is an fMLP agonist FEBS Lett. 540 2003 206 210
18. T. Nakamori Soy peptides as functional food ingredients Y. Mine, E. Li-Chan, B. Jiang, Bioactive Proteins and Peptides as Functional Foods and Neutraceuticals 2010 Wiley-Blackwell Ames 265 271
19. D. Young, M. Ibuki, T. Nakamori, M. Fan, and Y. Mine Soy-derived di- and tripeptides alleviate colon and ileum inflammation in pigs with dextran sodium sulfate-induced colitis J. Nutr. 142 2012 363 368
20. M. Maebuchi, M. Samoto, M. Kohno, R. Ito, T. Koikeda, M. Hirotsuka, and Y. Nakabou Improvement in the intestinal absorption of soy protein by enzymatic digestion to oligo-peptide in healthy adult men Food Sci. Technol. Res. 13 2007 45 53
21. W. Chanput, J. Mes, R.A. Vreeburg, H.F. Savelkoul, and H.J. Wichers Transcription profiles of LPS-stimulated THP-1 monocytes and macrophages: a tool to study inflammation modulating effects of food-derived compounds Food Funct. 1 2010 254 261
22. J.R. Maxwell, W.A. Brown, C.L. Smith, F.R. Byrne, and J.L. Viney Methods of inducing inflammatory bowel disease in mice Curr. Protoc. Pharmacol. 47 2009 5.58.1 5.58.37
23. S. Rozen, and H.J. Skaletsky Primer3 on the WWW for general users and for biologist programmers S. Krawetz, S. Misener, Bioinformatics Methods and Protocols: Methods in Molecular Biology 2000 Humana Press Totowa 365 386
24. - ΔΔCt method Methods 25 2001 402 408
25. F. Berlioz, J.-J. Maoret, H. Paris, M. Laburthe, R. Farinotti, and C. Rozé α2-Adrenergic receptors stimulate oligopeptide transport in a human intestinal cell line J. Pharmacol. Exp. Ther. 294 2000 466 472
26. I.J. Hidalgo, T.J. Raub, and R.T. Borchardt Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability Gastroenterology 96 1989 736 749
27. M. Satake, M. Enjoh, Y. Nakamura, T. Takano, Y. Kawamura, S. Arai, and M. Shimizu Transepithelial transport of the bioactive tripeptide, Val-Pro-Pro, in human intestinal Caco-2 cell monolayers Biosci. Biotechnol. Biochem. 66 2002 378 384
28. O. Masuda, Y. Nakamura, and T. Takano Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats J. Nutr. 126 1996 3063 3068
29. F. Yan, L. Wang, Y. Shi, H. Cao, L. Liu, M.K. Washington, R. Chaturvedi, D.A. Israel, H. Cao, B. Wang, R.M. Peek Jr., K.T. Wilson, and D.B. Polk Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice Am. J. Physiol. Gastrointest. Liver Physiol. 302 2012 G504 G514
30. M. Shimizu Interaction between food substances and the intestinal epithelium Biosci. Biotechnol. Biochem. 74 2010 232 241
31. R.P. MacDermott, I.R. Sanderson, and H.-C. Reinecker The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn's disease Inflamm. Bowel Dis. 4 1998 54 67
32. L. Charrier, A. Driss, Y. Yan, V. Nduati, J.M. Klapproth, S.V. Sitaraman, and D. Merlin hPepT1 mediates bacterial tripeptide fMLP uptake in human monocytes Lab. Investig. 86 2006 490 503
33. G.M. Charrière, W.E. Ip, S. Dejardin, L. Boyer, A. Sokolovska, M.P. Cappillino, B.J. Cherayil, D.K. Podolsky, K.S. Kobayashi, N. Silverman, A. Lacy-Hulbert, and L.M. Stuart Identification of Drosophila Yin and PEPT2 as evolutionarily conserved phagosome-associated muramyl dipeptide transporters J. Biol. Chem. 285 2010 20147 20154
34. G. Dalmasso, H.T. Nguyen, S.A. Ingersoll, S. Ayyadurai, H. Laroui, M.A. Charania, Y. Yan, S.V. Sitaraman, and D. Merlin The PepT1-NOD2 signaling pathway aggravates induced colitis in mice Gastroenterology 141 2011 1334 1345
35. M. Brandsch, Y. Miyamoto, V. Ganapathy, and F.H. Leibach Expression and protein kinase C-dependent regulation of peptide/H + co-transport system in the Caco-2 human colon carcinoma cell line Biochem. J. 299 1994 253 260
36. T. Matsui, X.L. Zhu, K. Watanabe, K. Tanaka, Y. Kusano, and K. Matsumoto Combined administration of captopril with an antihypertensive Val-Tyr di-peptide to spontaneously hypertensive rats attenuates the blood pressure lowering effect Life Sci. 79 2006 2492 2498
37. M. Miguel, A. Dávalos, M.A. Manso, G. de la Peña, M.A. Lasunción, and R. López-Fandiño Transepithelial transport across Caco-2 cell monolayers of antihypertensive egg-derived peptides. PepT1-mediated flux of Tyr-Pro-Ile Mol. Nutr. Food Res. 52 2008 1507 1513
38. Z. Liu, C. Wang, Q. Liu, Q. Meng, J. Cang, L. Mei, T. Kaku, and K. Liu Uptake, transport and regulation of JBP485 by PEPT1 in vitro and in vivo Peptides 32 2011 747 754
39. A. Vernaleken, M. Veyhl, V. Gorboulev, G. Kottra, D. Palm, B.C. Burckhardt, G. Burckhardt, R. Pipkorn, N. Beier, C. van Amsterdam, and H. Koepsell Tripeptides of RS1 (RSC1A1) inhibit a monosaccharide-dependent exocytotic pathway of Na+-D-glucose cotransporter SGLT1 with high affinity J. Biol. Chem. 282 2007 28501 28513
40. I. Okayasu, S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice Gastroenterology 98 1990 694 702
41. A.C. Chin, and C.A. Parkos Neutrophil transepithelial migration and epithelial barrier function in IBD potential targets for inhibiting neutrophil trafficking Ann. N. Y. Acad. Sci. 1072 2006 276 287
42. F. Costa, M.G. Mumolo, L. Ceccarelli, M. Bellini, M.R. Romano, and C. Sterpi Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than Crohn's disease Gut 54 2005 364 368
43. Y. Tang, F. Preuss, F.W. Turek, S. Jakate, and A. Keshavarzian Sleep deprivation worsens inflammation and delays recovery in a mouse model of colitis Sleep Med. 10 2009 597 603
44. S. Ardizzone, and G. Bianchi Porro Biologic therapy for inflammatory bowel disease Drugs 65 2005 2253 2286
45. B. Egger, M. Bajaj-Elliott, T.T. MacDonald, R. Inglin, V.E. Eysselein, and M.W. Büchler Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency Digestion 62 2000 240 248
46. S. Melgar, A. Karlsson, and E. Michaëlsson Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation Am. J. Physiol. Gastrointest. Liver Physiol. 288 2005 G1328 G1338
47. F. Obermeier, G. Kojouharoff, W. Hans, J. Schölmerich, V. Gross, and W. Falk Interferon-gamma (IFN-γ)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice Clin. Exp. Immunol. 116 1999 238 245
48. K.H. Kwon, A. Murakami, R. Hayashi, and H. Ohigashi Interleukin-1β targets interleukin-6 in progressing dextran sulfate sodium-induced experimental colitis Biochem. Biophys. Res. Commun. 337 2005 647 654
49. G. Bamias, and F. Cominelli Immunopathogenesis of inflammatory bowel disease: current concepts Curr. Opin. Gastroenterol. 23 2007 365 369
50. T.T. MacDonald, I. Monteleone, M.C. Fantini, and G. Monteleone Regulation of homeostasis and inflammation in the intestine Gastroenterology 140 2011 1768 1775
51. M. Hausmann, F. Obermeier, D.H. Paper, K. Balan, N. Dunger, K. Menzel, W. Falk, J. Schoelmerich, H. Herfarth, and G. Rogler In vivo treatment with the herbal phenylethanoid acteoside ameliorates intestinal inflammation in dextran sulphate sodium-induced colitis Clin. Exp. Immunol. 148 2007 373 381
52. T. Kucharzik, R. Stoll, N. Lugering, and W. Domschke Circulating anti-inflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD) Clin. Exp. Immunol. 100 1995 452 456
53. D.R. Foster, C.P. Landowski, X. Zheng, G.L. Amidon, and L.S. Welage Interferon-γ increases expression of the di/tri-peptide transporter, h-PEPT1, and dipeptide transport in cultured human intestinal monolayers Pharmacol. Res. 59 2009 215 220